4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001834021-26-000002
See Remarks sold 114,746 shares at $10.47 ($1,200,851)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kirn David See Remarks | 2026-06-22 | Sale 10b5-1 | −114,746 | $10.47 | $1,200,851 | 942,485 | D |
| Open-market sales · 114,746 sh · avg $10.47 · $1,200,851 | |||||||
Loading xslF345X06/ownership.xml…